馬泰勒蟲免疫熒光試劑盒

theileria equi IFA Kit

廣州健侖生物科技有限公司

主要用途：用于檢測(cè)馬血清中的馬泰勒蟲IgG/IgM抗體

產(chǎn)品規(guī)格：12 孔/張,10 張/盒

主要產(chǎn)品包括：包柔氏螺旋體菌、布魯氏菌、貝納特氏立克次體、土倫桿菌、鉤端螺旋體、新型立克次體、恙蟲病、立克次體、果氏巴貝西蟲、馬焦蟲、牛焦蟲、利什曼蟲、新包蟲、弓形蟲、貓流感病毒、貓冠狀病毒、貓皰疹病毒、犬瘟病毒、犬細(xì)小病毒等病原微生物的 IFA、MIF、ELISA試劑。

馬泰勒蟲免疫熒光試劑盒

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無(wú)形體、蜱蟲、恙蟲、利什曼原蟲、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢2042552662

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

在胰腺β細(xì)胞內(nèi)葡萄糖的代謝對(duì)于胰島素基因表達(dá)和胞外分泌的賀爾蒙來(lái)說(shuō)是很關(guān)鍵的一環(huán)，但是有越來(lái)越多的證據(jù)顯示，葡萄糖代謝途徑同時(shí)對(duì)于β-細(xì)胞發(fā)育和維持成年人的β細(xì)胞質(zhì)量非常重要。在小鼠β細(xì)胞中針對(duì)葡萄糖激酶剃除后不僅防止了葡萄糖所刺激的胰島素分泌，而且也抑制了β細(xì)胞的增殖，并與細(xì)胞凋亡的增加有關(guān)聯(lián)。在組織培養(yǎng)中，直接操縱胚胎胰臟的葡萄糖可用性實(shí)驗(yàn)則顯示了轉(zhuǎn)錄調(diào)控因子神經(jīng)元素3(Neurog3)和NEUROD對(duì)于α和β細(xì)胞的發(fā)育是很必要的存在。
針對(duì)此主題，帕特爾等人的論文提到丙酮酸脫氫酶α組件是丙酮酸脫氫酶復(fù)合物調(diào)控丙酮酸代謝的速率決定酵素;在老鼠實(shí)驗(yàn)?zāi)Ｊ街刑蕹?beta;細(xì)胞的丙酮酸脫氫酶α組件之后，如同預(yù)期的會(huì)引起胰島素可用性降低以及葡萄糖敏感性釋放，但是卻也同時(shí)觀察到新生老鼠β細(xì)胞數(shù)目減少以及Neurog3，NEUROD和的Pdx1的表達(dá)。有趣的是，同時(shí)也在胰島素免疫陽(yáng)性，特胰島的內(nèi)分泌小細(xì)胞簇中看到數(shù)目的減少，意味著也減少了新生β-細(xì)胞的來(lái)源。這個(gè)新發(fā)現(xiàn)強(qiáng)調(diào)了β-細(xì)胞中控制葡萄糖代謝的途徑對(duì)于維持β-細(xì)胞質(zhì)量以及賀爾蒙和生長(zhǎng)因子，例如胰高血糖素樣多肽1(GLP1)是同等重要的。
此研究主題刊登于2014年8月的《實(shí)驗(yàn)生物及醫(yī)學(xué)》，證明了丙酮酸脫氫酶復(fù)合體不僅對(duì)于胰島素基因表達(dá)和葡萄糖刺激的胰島素分泌非常必要，同時(shí)還直接影響β-細(xì)胞的生長(zhǎng)和成熟，更闡明了葡萄糖代謝會(huì)直接調(diào)控β細(xì)胞質(zhì)量和可塑性。
紐約州立大學(xué)水牛城分校生物化學(xué)、醫(yī)學(xué)和生物醫(yī)學(xué)科學(xué)學(xué)院的特聘教授，同時(shí)也是*作者的莫成?帕特爾博士說(shuō)道：“這些發(fā)現(xiàn)顯示了葡萄糖代謝是調(diào)控β細(xì)胞質(zhì)量的主要調(diào)控因子，很可能是獨(dú)立的訊息傳遞路徑，例如可能不同于胰島素受體作用物2訊息傳遞路徑。”

Glucose metabolism in pancreatic beta cells is a crucial link to hormonal gene expression and extracellular secretion of hormones, but there is growing evidence that glucose metabolism contributes both to beta-cell development and maintenance of adulthood Human β-cell mass is very important. Shaved for glucokinase in mouse beta cells not only prevents glucose-stimulated insulin secretion but also inhibits beta cell proliferation and correlates with increased apoptosis. Glucose availability experiments directly manipulating embryonic pancreas in tissue culture showed that the transcriptional regulators Neurog3 and NEUROD are essential for the development of alpha and beta cells.
In response to this topic, Pa et al.'s paper mentions that the pyruvate dehydrogenase alpha component is a pyruvate dehydrogenase complex that regulates the rate at which pyruvate is metabolized; removing pyruvate from beta cells in experimental models of rats After the hydrogenase α-component, as expected, a decrease in insulin availability and glucose-sensitive release was caused, however, a decrease in the number of β-cells in neonatal mice and the expression of Neurog3, NEUROD and Pdx1 were also observed. Interestingly, a decrease in the number seen also in insulin-immunoreactive, insulinotropic endocrine small cell clusters means that the source of nascent β-cells is also reduced. This new finding emphasizes that the pathways that control glucose metabolism in β-cells are equally important for maintaining β-cell mass and for hormones and growth factors such as glucagon-like polypeptide 1 (GLP1).
The subject of the study, published in August 2014, "Experimental Biology and Medicine," demonstrates that pyruvate dehydrogenase complexes are essential not only for insulin gene expression and glucose-stimulated insulin secretion, but also for β-cell growth and Mature, but also shows that glucose metabolism will directly regulate β-cell quality and plasticity.
Dr. Moblie Pa, Distinguished Professor of Biochemistry, Medical and Biomedical Sciences at the State University of New York at Buffalo, said: "These findings show that glucose metabolism is a major regulator of beta-cell mass, Probably an independent messaging pathway, for example, may differ from the insulin receptor 2 signaling pathway.